1. Home
  2. ATPC vs CTSO Comparison

ATPC vs CTSO Comparison

Compare ATPC & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATPC
  • CTSO
  • Stock Information
  • Founded
  • ATPC 2016
  • CTSO 1997
  • Country
  • ATPC Malaysia
  • CTSO United States
  • Employees
  • ATPC N/A
  • CTSO N/A
  • Industry
  • ATPC Medical/Nursing Services
  • CTSO Medical/Dental Instruments
  • Sector
  • ATPC Health Care
  • CTSO Health Care
  • Exchange
  • ATPC Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • ATPC 63.0M
  • CTSO 58.6M
  • IPO Year
  • ATPC N/A
  • CTSO N/A
  • Fundamental
  • Price
  • ATPC $1.22
  • CTSO $0.71
  • Analyst Decision
  • ATPC
  • CTSO Buy
  • Analyst Count
  • ATPC 0
  • CTSO 2
  • Target Price
  • ATPC N/A
  • CTSO $5.50
  • AVG Volume (30 Days)
  • ATPC 46.5K
  • CTSO 79.9K
  • Earning Date
  • ATPC 11-14-2025
  • CTSO 11-13-2025
  • Dividend Yield
  • ATPC N/A
  • CTSO N/A
  • EPS Growth
  • ATPC N/A
  • CTSO N/A
  • EPS
  • ATPC N/A
  • CTSO N/A
  • Revenue
  • ATPC $1,445,601.00
  • CTSO $36,107,520.00
  • Revenue This Year
  • ATPC N/A
  • CTSO $11.93
  • Revenue Next Year
  • ATPC N/A
  • CTSO $21.22
  • P/E Ratio
  • ATPC N/A
  • CTSO N/A
  • Revenue Growth
  • ATPC 4.90
  • CTSO 20.18
  • 52 Week Low
  • ATPC $0.90
  • CTSO $0.71
  • 52 Week High
  • ATPC $2.93
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • ATPC 49.08
  • CTSO 27.60
  • Support Level
  • ATPC $1.18
  • CTSO $0.74
  • Resistance Level
  • ATPC $1.30
  • CTSO $0.80
  • Average True Range (ATR)
  • ATPC 0.06
  • CTSO 0.04
  • MACD
  • ATPC 0.00
  • CTSO -0.01
  • Stochastic Oscillator
  • ATPC 27.78
  • CTSO 1.49

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: